IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,855 | -83.7% | 810 | -80.6% | 0.00% | -100.0% |
Q2 2023 | $78,670 | +2428.8% | 4,169 | +414.7% | 0.00% | – |
Q1 2023 | $3,111 | -22.6% | 810 | 0.0% | 0.00% | – |
Q4 2022 | $4,018 | +0.4% | 810 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 810 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 810 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -33.3% | 810 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | +20.0% | 810 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | 0.0% | 810 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | -28.6% | 810 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | +40.0% | 810 | 0.0% | 0.00% | – |
Q4 2020 | $5,000 | +66.7% | 810 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | -25.0% | 810 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | +33.3% | 810 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | -25.0% | 810 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | +100.0% | 810 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 810 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -50.0% | 810 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $4,000 | – | 810 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |